SuperworthiBio market cap IBIO
Share price times shares outstanding: what the whole company sells for, since 2011.
- Today, Oct 23, 2026
- $46.2M
- Highest close in our data
- $651M
- Jul 2020
iBio is worth $46.2M at the close on Oct 23, 2026, at $0.72 a share.
That is up 94% over the last year and down 73% over five years.
Its highest close in our data was $651M in Jul 2020.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $46.2M | $45.4M | $97.4M | +9% |
| 2025 | $42.5M | $8.8M | $57.6M | +90% |
| 2024 | $22.4M | $1.5M | $26.9M | +1065% |
| 2023 | $1.9M | $1.8M | $26M | −51% |
| 2022 | $4M | $3.5M | $113.3M | −97% |
| 2021 | $119.9M | $119.9M | $440.7M | −37% |
| 2020 | $191.2M | $7.3M | $651M | +2504% |
| 2019 | $7.3M | $3.5M | $18.7M | −43% |
| 2018 | $12.9M | $7.5M | $31.1M | −23% |
| 2017 | $16.7M | $13.9M | $46.3M | −53% |
| 2016 | $35.6M | $34.8M | $65.9M | −18% |
| 2015 | $43.3M | $31.6M | $79.2M | −10% |
| 2014 | $48.2M | $22.6M | $216.5M | +102% |
| 2013 | $23.8M | $16.4M | $37.7M | −24% |
| 2012 | $31.5M | $25.3M | $86M | +17% |
| 2011 | $26.9M | $25.3M | $52.8M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest iBio's size, closest first, today.
| Company | Market cap |
|---|---|
| IBIOiBio | $46.2M |
| ATNMActinium Pharmaceuticals | $47.8M |
| SPROSpero Therapeutics | $64.6M |
| LFVNLifevantage | $73.4M |
| NATRNatures Sunshine Products | $213.8M |
| Peer median | $69M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on iBio
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.